PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Oncology and Haematology, Kantonsspital St Gallen, Sankt Gallen, Switzerland.\', \'Coordinating Center, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.\', \'Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK.\', \'Department Medical Oncology, Gustave Roussy, Villejuif, Île-de-France, France.\', \'Medical Oncology, Royal Marsden Hospital NHS Trust, London, London, UK.\', \'Clinic for Internal Medicine (Tumor Research) and Clinic for Urology, University Hospital Essen, Essen, Germany.\', \'Kidney Cancer Program, Dana-Farber/Harvard Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.\', \'Division of Medicine an Laboratory Sciences, Akershus University Hospital, Lorenskog, Norway.\', \'Biomedical Sciences and Human Oncology, Università degli Studi di Bari Aldo Moro, Bari, Italy.\', \'Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Medicine I, Clinical Division of Oncology, Vienna, Austria.\', \'Medical Oncology, Weill Cornell Medicine, New York, New York, USA.\', \'Medical Oncology and Haematology, Kantonsspital St Gallen, Sankt Gallen, Switzerland christian.rothermundt@kssg.ch.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00085210.1136/esmoopen-2020-000852
?:doi
?:hasPublicationType
?:journal
  • ESMO open
is ?:pmid of
?:pmid
?:pmid
  • 32669298
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all